A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast CancersAshton C. Berger, Carolyn M. Hutter, Xubin Li et al.|Cancer Cell|2018Cited by 701
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistanceDeyin Xing, Sandra Oršulić|Proceedings of the National Academy of Sciences|2005Cited by 99
Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancerJessica A. Beach, Sandra Oršulić|Oncotarget|2015Cited by 59
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancerYe Hu, Sandra Oršulić|npj Precision Oncology|2024Cited by 39
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinomaAlexander M. Xu, Sandra Oršulić|Science Advances|2024Cited by 26